静态负荷对慢性乙型肝炎和C型肝炎的影响:叙述性综述
Chukwuemeka E Ogbu1, John N Kalu1, Maureen Ezechukwu1
1Internal Medicine, Cape Fear Valley Health, Fayetteville, USA.
Cureus
|October 16, 2025
概括
静态负荷,身体对慢性压力的反应,通过影响免疫功能和炎症,有助于各种各样的乙型肝炎 (HBV) 和C型肝炎 (HCV) 进展. 解决压力和社会因素是改善患者治疗结果的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
- 心理神经免疫学 心理神经免疫学
背景情况:
- 慢性乙型肝炎 (HBV) 和C型肝炎 (HCV) 的临床进展表现出不仅仅由病毒因素解释的变异性.
- 静态负荷,慢性压力的累积生理负担,被探索为贡献宿主因素.
研究的目的:
- 审查全静电负荷在HBV和HCV临床进展异质性中的作用.
- 探索全静电负荷如何影响免疫失调,肝炎和病毒性肝炎的临床结果.
主要方法:
- 来自主要数据库和灰色文献的英语语言研究的叙事综合.
- 包括多样化的研究设计 (横截面,队列,临床试验) 和生物机制临床前研究.
- 由于存在显著的异质性,研究结果的专题总结.
主要成果:
- 慢性压力通过神经内分泌路径 (HPA轴,交感神经系统) 破坏肝脏免疫恒温,增加炎症并降低抗病毒免疫力.
- 心理社会压力和抑郁症与抗病毒疗法 (特别是HCV) 坚持性降低有关,并可能加剧疾病爆发和纤维化.
- 健康的社会决定因素 (贫困,创伤,监禁) 增加全静电负荷,造成护理障碍,并加剧健康差异.
结论:
- 静态负荷为理解HBV/HCV异质性提供了生物心理社会框架,在HCV中更为确立的联系.
- 对全静电负荷影响的临床证据有限且异质,需要进一步研究.
- 未来的研究应侧重于使用标准化压力生物标志物的前性研究和解决心理健康和结构性障碍的综合护理模型.
相关概念视频
01:22Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
180
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
180
01:26Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
211
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
211
01:08Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
249
Hepatic impairment, characterized by decreased liver function, does not uniformly mandate adjustments in drug dosage. Whether dosage modifications are necessary depends on various factors related to the drug's metabolism and elimination pathways. If a drug is primarily excreted via the kidneys and bypasses significant hepatic processing, if it undergoes minimal metabolic transformation in the liver, or if it is volatile and primarily expelled through the lungs, dose adjustments may not be...
249
01:26Diseases of the Liver and Gallbladder
1.8K
Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
1.8K
01:24Chronic Pancreatitis I: Introduction
664
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
664
01:14Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
210
In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
210